Stanley Shaw, MD, PhD is the Chief Scientific Officer (CSO) for the One Brave Idea initiative, Associate Dean for Executive Education at Harvard Medical School, and an Associate Member of the Broad Institute of Harvard and MIT. His research has sought to develop new phenotypes (measurable traits) for the assessment of human wellness and disease, through the study of patient-derived cells, Electronic Health Records (EHR), the gut microbiome and digital health. His team led the development of one of the first ResearchKit apps (for type 2 diabetes) in partnership with Apple. Previously, Dr. Shaw was co-founder and co-director of the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital (MGH), and a founding Principal Investigator in the MGH Center for Systems Biology. He is a board-certified cardiologist.